SCHEMBL10353387

SCHEMBL10353387

O=C1CC[S+]([O-])c2ccccc2N1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.47
MAPK13 O15264 1/20 0.47
MAPK12 P53778 1/20 0.47
MAPK11 Q15759 1/20 0.47
MAPK14 Q16539 1/20 0.47
MAPT P10636 1/20 0.44
AHR P35869 1/20 0.40
PDK2 Q15119 1/20 0.40
PLCG1 P19174 1/20 0.36
BRD4 O60885 7/20 0.35
CREBBP Q92793 7/20 0.35
CA9 Q16790 1/20 0.35
EP300 Q09472 1/20 0.35
CCNT1 O60563 1/20 0.33
CCNB2 O95067 1/20 0.33
CDK1 P06493 1/20 0.33
CCNB1 P14635 1/20 0.33
CCNA2 P20248 1/20 0.33
CDK2 P24941 1/20 0.33
GSK3B P49841 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9628930 0.90 MAPT (0.50) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL88930 0.81 AHR (0.42) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL8853443 0.79 MEN1 (0.40) NPC1MAPTALDH1A1
SCHEMBL3493955 0.69 MAOA (0.41) NPC1MAPTPLCG1GSK3BALDH1A1
SCHEMBL88860 0.69 MEN1 (0.34) NPC1MAPTALDH1A1
SCHEMBL10352552 0.68 CREBBP (0.50) BRD4CREBBPEP300ALDH1A1TSHR
SCHEMBL15349083 0.68
SCHEMBL11701479 0.67 CA12 (0.39) NPC1MAPK13MAPK12MAPK11MAPK14
SCHEMBL7347184 0.67 MEN1 (0.32) ALDH1A1
SCHEMBL89000 0.67 MEN1 (0.42) NPC1MAPTCCNB2CDK1CCNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4291558-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2023-12-20 EP claimed
WO-2022171745-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2022-08-18 WO claimed
WO-2014125444-A1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2014-08-21 WO disclosed
EP-0292824-B1 PROCESS FOR THE NUCLEAR CHLORINATION OF AROMATIC HYDROCARBONS BAYER AG (DE) 1990-08-01 EP disclosed
EP-0292824-A1 Process for the nuclear chlorination of aromatic hydrocarbons BAYER AG (DE) 1988-11-30 EP disclosed